{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T08:10:08Z","timestamp":1744445408780,"version":"3.40.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"crossref","award":["320.6750.18013"],"award-info":[{"award-number":["320.6750.18013"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"crossref","award":["2020-2-2033"],"award-info":[{"award-number":["2020-2-2033"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96315-w","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T07:49:01Z","timestamp":1744444141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and prognostic factors guiding diagnosis and treatment of prostate diffuse large B-cell lymphoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Yirui","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pushen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"issue":"10","key":"96315_CR1","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.5858\/arpa.2014-0276-CC","volume":"138","author":"JI Warrick","year":"2014","unstructured":"Warrick, J. I., Owens, S. R. & Tomlins, S. A. Diffuse large B-cell lymphoma of the prostate. Arch. Pathol. Lab. Med. 138 (10), 1286\u20131289 (2014).","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"6","key":"96315_CR2","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/S0022-5347(01)67330-0","volume":"153","author":"A Sarris","year":"1995","unstructured":"Sarris, A., Dimopoulos, M., Pugh, W. & Cabanillas, F. Primary lymphoma of the prostate: good outcome with doxorubicin-based combination chemotherapy. J. Urol. 153 (6), 1852\u20131854 (1995).","journal-title":"J. Urol."},{"issue":"10310","key":"96315_CR3","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/S0140-6736(20)32207-8","volume":"398","author":"P Brice","year":"2021","unstructured":"Brice, P., de Kerviler, E. & Friedberg, J. W. Classical hodgkin lymphoma. Lancet 398 (10310), 1518\u20131527 (2021).","journal-title":"Lancet"},{"issue":"9844","key":"96315_CR4","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland, K. R., Armitage, J. O. & Hancock, B. W. Non-hodgkin lymphoma. Lancet 380 (9844), 848\u2013857 (2012).","journal-title":"Lancet"},{"issue":"4","key":"96315_CR5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<732::AID-CNCR15>3.0.CO;2-T","volume":"83","author":"DG Bostwick","year":"1998","unstructured":"Bostwick, D. G., Iczkowski, K. A., Amin, M. B., Discigil, G. & Osborne, B. Malignant lymphoma involving the prostate: report of 62 cases. Cancer 83 (4), 732\u2013738 (1998).","journal-title":"Cancer"},{"issue":"8","key":"96315_CR6","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1016\/j.asjsur.2023.03.040","volume":"46","author":"X Chen","year":"2023","unstructured":"Chen, X., Tan, Z. & Duan, X. Primary diffuse large B-cell lymphoma of the prostate: A case report. Asian J. Surg. 46 (8), 3302\u20133303 (2023).","journal-title":"Asian J. Surg."},{"key":"96315_CR7","doi-asserted-by":"publisher","first-page":"102497","DOI":"10.1016\/j.eucr.2023.102497","volume":"50","author":"E Ochirjav","year":"2023","unstructured":"Ochirjav, E., Tsedenbal, B., Enkhjargal, M., Mendbayar, E. & Sharkhuu, E. Hematolymphoid tumor of prostate: diffuse large B cell lymphoma case report. Urol. Case Rep. 50, 102497 (2023).","journal-title":"Urol. Case Rep."},{"key":"96315_CR8","doi-asserted-by":"crossref","unstructured":"SEER* stat software. National Cancer Institute Surveillance, Epidemiology, and End Results. Program(SEER). https:\/\/seer.cancer.gov\/seerstat\/ (2024).","DOI":"10.1093\/jncimonographs\/lgae033"},{"issue":"2","key":"96315_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/1066896916665203","volume":"25","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. High frequency of bone marrow involvement in intravascular large B-cell lymphoma. Int. J. Surg. Pathol. 25 (2), 118\u2013126 (2017).","journal-title":"Int. J. Surg. Pathol."},{"issue":"7","key":"96315_CR10","first-page":"e16198","volume":"13","author":"S Hassanzadeh","year":"2021","unstructured":"Hassanzadeh, S., Mackrides, N., Rastegar, S. & Nejati, R. Diffuse large B-cell lymphoma with a background of extensive granulomatous inflammation: A potential pitfall for misdiagnosis. Cureus 13 (7), e16198 (2021).","journal-title":"Cureus"},{"issue":"5","key":"96315_CR11","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/his.14045","volume":"76","author":"S P\u00e9ricart","year":"2020","unstructured":"P\u00e9ricart, S. et al. Exclusive B-cell phenotype of primary prostatic lymphomas: a potential role of chronic prostatitis. Histopathology 76 (5), 767\u2013773 (2020).","journal-title":"Histopathology"},{"issue":"1","key":"96315_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/iju5.12541","volume":"6","author":"T Ujiie","year":"2023","unstructured":"Ujiie, T. et al. Primary diffuse large B cell lymphoma of the prostate in a patient with HIV infection. IJU Case Rep. 6 (1), 30\u201332 (2023).","journal-title":"IJU Case Rep."},{"key":"96315_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/BLCTT.S407086","volume":"13","author":"T Gessese","year":"2023","unstructured":"Gessese, T., Asrie, F. & Mulatie, Z. Human immunodeficiency virus related non-hodgkin\u2019s lymphoma. Blood Lymphat Cancer  13, 13\u201324 (2023).","journal-title":"Blood Lymphat Cancer"},{"issue":"7","key":"96315_CR14","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.12998\/wjcc.v11.i7.1627","volume":"11","author":"TF Chen","year":"2023","unstructured":"Chen, T. F., Lin, W. L., Liu, W. Y. & Gu, C. M. Prostate lymphoma with renal obstruction; reflections on diagnosis and treatment: two case reports. World J. Clin. Cases  11 (7), 1627\u20131633 (2023).","journal-title":"World J. Clin. Cases"},{"key":"96315_CR15","doi-asserted-by":"publisher","first-page":"101945","DOI":"10.1016\/j.eucr.2021.101945","volume":"40","author":"F Harley","year":"2022","unstructured":"Harley, F., Dias, B., Dow, C. & Ooi, J. Primary non-metastatic extra-nodal diffuse large B-cell lymphoma of the prostate and seminal vesicle. Urol. Case Rep. 40, 101945 (2022).","journal-title":"Urol. Case Rep."},{"issue":"4","key":"96315_CR16","doi-asserted-by":"publisher","first-page":"977","DOI":"10.4103\/0973-1482.176122","volume":"11","author":"A Kakkar","year":"2015","unstructured":"Kakkar, A. et al. Primary diffuse large B-cell lymphoma of the prostate: A report of two cases with diagnostic considerations. J. Cancer Res. Ther. 11 (4), 977\u2013979 (2015).","journal-title":"J. Cancer Res. Ther."},{"issue":"23","key":"96315_CR17","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/blood.2019002729","volume":"135","author":"AS Ruppert","year":"2020","unstructured":"Ruppert, A. S. et al. International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI. Blood 135 (23), 2041\u20132048 (2020).","journal-title":"Blood"},{"issue":"13","key":"96315_CR18","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/pros.24758","volume":"84","author":"Y Wei","year":"2024","unstructured":"Wei, Y. et al. Analysis of three primary prostatic sarcoma cases and literature review. Prostate 84 (13), 1218\u20131223 (2024).","journal-title":"Prostate"},{"issue":"7","key":"96315_CR19","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2967\/jnumed.117.202721","volume":"59","author":"B Enilorac","year":"2018","unstructured":"Enilorac, B. et al. Does PET reconstruction method affect Deauville score in lymphoma patients? J. Nucl. Med. 59 (7), 1049\u20131055 (2018).","journal-title":"J. Nucl. Med."},{"issue":"10","key":"96315_CR20","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1080\/10428190701584007","volume":"48","author":"H He","year":"2007","unstructured":"He, H., Cheng, L., Weiss, L. M. & Chu, P. G. Clinical outcome of incidental pelvic node malignant B-cell lymphomas discovered at the time of radical prostatectomy. Leuk. Lymphoma  48 (10), 1976\u20131980 (2007).","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"96315_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/01.pas.0000153122.65138.b1","volume":"29","author":"PG Chu","year":"2005","unstructured":"Chu, P. G., Huang, Q. & Weiss, L. M. Incidental and concurrent malignant lymphomas discovered at the time of prostatectomy and prostate biopsy: a study of 29 cases. Am. J. Surg. Pathol. 29 (5), 693\u2013699 (2005).","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"96315_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans, C. P. et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (1), 275\u2013282 (2004).","journal-title":"Blood"},{"key":"96315_CR23","doi-asserted-by":"publisher","first-page":"842093","DOI":"10.3389\/fmed.2022.842093","volume":"9","author":"F Jiang","year":"2022","unstructured":"Jiang, F. et al. 18F-prostate-specific membrane antigen and 18F-fluorodeoxyglucose PET\/CT unmasked the characteristics of prostate lymphoma: A case report and literature review. Front. Med. (Lausanne)  9, 842093 (2022).","journal-title":"Front. Med. (Lausanne)"},{"issue":"1","key":"96315_CR24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1186\/s13256-021-03143-3","volume":"15","author":"M Ren","year":"2021","unstructured":"Ren, M. & Liu, Y. Primary diffuse large B-cell lymphoma of the prostate: a case report and review of the literature. J. Med. Case Rep. 15 (1), 546 (2021).","journal-title":"J. Med. Case Rep."},{"key":"96315_CR25","doi-asserted-by":"publisher","first-page":"205873841986321","DOI":"10.1177\/2058738419863217","volume":"33","author":"K Wang","year":"2019","unstructured":"Wang, K., Wang, N., Sun, J., Fan, Y. & Chen, L. Primary prostate lymphoma: A case report and literature review. Int. J. Immunopathol. Pharmacol. 33, 2058738419863217 (2019).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"4","key":"96315_CR26","first-page":"412","volume":"16","author":"A Jafari","year":"2019","unstructured":"Jafari, A., Mofid, B., Tabibi, A. & Kowsari, F. Primary prostate lymphoma managed with combined modality treatment: A case report. Urol. J. 16 (4), 412\u2013414 (2019).","journal-title":"Urol. J."},{"issue":"4","key":"96315_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41408-021-00456-w","volume":"11","author":"BD Cheson","year":"2021","unstructured":"Cheson, B. D., Nowakowski, G. & Salles, G. Diffuse large B-cell lymphoma: new targets and novel therapies. Blood Cancer J. 11 (4), 68 (2021).","journal-title":"Blood Cancer J."},{"issue":"15","key":"96315_CR28","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz, R. et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl. J. Med. 378 (15), 1396\u20131407 (2018).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"96315_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41408-024-00997-w","volume":"14","author":"A Trabolsi","year":"2024","unstructured":"Trabolsi, A., Arumov, A. & Schatz, J. H. Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas. Blood Cancer J. 14 (1), 27 (2024).","journal-title":"Blood Cancer J."},{"issue":"8","key":"96315_CR30","first-page":"445","volume":"57","author":"N Kishimoto","year":"2011","unstructured":"Kishimoto, N. et al. A case of primary malignant lymphoma of the prostate. Hinyokika Kiyo  57 (8), 445\u2013449 (2011).","journal-title":"Hinyokika Kiyo"},{"issue":"1","key":"96315_CR31","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.asjsur.2023.09.128","volume":"47","author":"H Duan","year":"2024","unstructured":"Duan, H., Deng, Z., Zhang, G. & Xie, T. Diffuse large B-cell lymphoma of the prostate: A case report. Asian J. Surg. 47 (1), 604\u2013605 (2024).","journal-title":"Asian J. Surg."},{"issue":"1","key":"96315_CR32","doi-asserted-by":"publisher","first-page":"ltab001","DOI":"10.1093\/immadv\/ltab001","volume":"1","author":"P Greve","year":"2021","unstructured":"Greve, P., Meyer-Wentrup, F. A. G., Peperzak, V. & Boes, M. Upcoming immunotherapeutic combinations for B-cell lymphoma. Immunother. Adv. 1 (1), ltab001 (2021).","journal-title":"Immunother Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96315-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96315-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96315-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T07:49:05Z","timestamp":1744444145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96315-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96315"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96315-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and approved by the Ethics Review Committee of Beijing Chaoyang Hospital, Capital Medical University (Ethics Approval No. 2024-science-582-1). Informed consent was obtained from all patients for participation in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study has been approved by all authors for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"12594"}}